Completed OBSERVATIONAL NCT03497741

Predictive Value of Procalcitonin for Bacteremia in the ICU

Sponsor: Rijnstate Hospital

Updated 7 times since 2018 Last updated: Jun 18, 2024 Started: Oct 1, 2017 Primary completion: Jan 1, 2019 Completion: Mar 1, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03497741, this observational or N/A phase trial focuses on Procalcitonin and Sepsis and remains completed. Sponsored by Rijnstate Hospital, it has been updated 7 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed

Status: Unknown Status → Completed
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Nov 2020 — Jan 2021 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Nov 2018 — Nov 2020 [monthly]

Recruiting

▶ Show 2 earlier versions

Jun 2018 — Nov 2018 [monthly]

Recruiting
May 2018 — Jun 2018 [monthly]

Recruiting

First recorded

Oct 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Rijnstate Hospital

Data source: Rijnstate Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Arnhem, Netherlands